ALVAL — Valbiotis SA Cashflow Statement
0.000.00%
Last trade - 00:00- €23.85m
- €20.26m
- €0.91m
Annual cashflow statement for Valbiotis SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.68 | -12.3 | -7.37 | -10 | -9.42 |
| Depreciation | |||||
| Non-Cash Items | 1.45 | 2.32 | 0.591 | 0.825 | 2.42 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.863 | -0.053 | -2.01 | -2.92 | -1.34 |
| Change in Accounts Receivable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.16 | -9.19 | -8.05 | -11.5 | -8.04 |
| Capital Expenditures | -0.421 | -0.288 | -0.247 | -0.261 | -0.151 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.414 | 0.091 | -0.003 | 0.2 | 0.074 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.007 | -0.197 | -0.25 | -0.061 | -0.077 |
| Financing Cash Flow Items | — | — | — | — | -0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.4 | 8.4 | 12.5 | -1.84 | 5.21 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 7.24 | -0.988 | 4.19 | -13.4 | -2.9 |